- As a leading innovator in brain diagnostics technology, BRSF appears well placed to spot and predict driving forces behind the industry’s expected rapid growth
- BRSF’s Marketing Director was featured in an article giving prediction about key trends driving brain monitoring space in 2021
- BRSF poised to remain at EEG forefront as exciting new opportunities lay ahead for this growing sector
Recognized as a leading innovative player in the brain monitoring space, Brain Scientific (OTCQB: BRSF) continues to be at the forefront of what is next in neurology technology. The Company’s Marketing Director, Irina Nazarova, was featured in Tech Times, a publication reporting on the latest innovations and developments in technology, science, and health industries, where she outlined key brain monitoring trends to watch in 2021 (https://ibn.fm/txDqZ).
Technology is advancing at an accelerated rate, pushing boundaries on what is possible and at what costs across neurology medical devices. As a result, brain monitoring is becoming as popular and widespread as monitoring pulse or heart rate, Nazarova notes.
With technology becoming ever more ubiquitous, one of the key trends involves cross-industry cooperation and expansion into new markets. For example, EEG coupled with virtual reality technology has enabled the development of the so-called brain-computer interface (“BCI”). This VR neuro interface activates a direct communication pathway between a user’s brain and an external device. Monitoring brain activity in a virtual reality setting with feedback also allows for collecting valuable data with a range of potential implementations, from brain-controlled games to post-stroke rehabilitation and recovery.
Although the technology has been around for decades, the recent solutions brought the increasing ease of use on one side and dwindling costs of use on the other, allowing it to enter the day-to-day lives of a growing number of people. As a result, the number of potential applications has swelled and EEG monitoring is no longer a preserve of clinicians and expert neuroscientific researchers. For example, EEG allows applications of neuroscience methods to explore cognitive processes that are believed to drive consumer behavior. Over the past decade, marketing research has adopted neuroscience techniques to unveil conscious and unconscious consumer behavior drivers. The market for neuromarketing is expected to grow at a CAGR of 8.89% during 2021-2026, increasing from $1.2 billion in 2020 to 1.9 billion by 2026 (https://ibn.fm/W3JUi). Often, EEG is the technique of choice in consumer neuroscience research due to its low cost and high temporal resolution (https://ibn.fm/sE8PX).
Brain monitoring technology is also deployed in the business environment, where it attempts to analyze employees’ brain activity to develop data-driven predictions or streamline business processes to boost efficiency and quality of the work.
Nazarova further points out that as the industry matures, players are moving away from universal products to create more niche solutions. These solutions are designed for specific tasks such as attention-tracking or memory improvement, boosting the demand for white-label EEG solutions.
EEG monitoring is also expected to find further applications in providing businesses with science-backed evidence. This application could be especially helpful for companies seeking to demonstrate to consumers the efficacy of their products. With this goal in mind, it could be deployed across several fields such as meditation, sport, education, and arts, where it could help document users’ brain activity as a response to certain products.
Finally, telemedicine is another application field where neurofeedback and biofeedback platforms have been appearing on the market.
Exciting new opportunities are potentially in front of EEG technology. EEG-based products go beyond the medical space and are on their way to penetrate new sectors and find more uses. Brain Scientific is committed to remaining a key innovative leader in what could potentially be a rapidly growing market over the next years.
For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.